AYTU - Company ID 0001385818
The table below shows AYTU BIOPHARMA, INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $26.31M | $30.95M | $20.01M | $22.98M | $19.36M | $49.65M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $22.78M | $31.16M | $23.62M | $28.94M | $21.71M | $28.18M |
| Inventory | $6.86M | $11.43M | $12.63M | $11.99M | $10.85M | $16.34M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $61.76M |
| $79.18M |
| - |
| $72.83M |
| $59.93M |
| $105.23M |
| Property, plant & equipment | $385.00K | $532.00K | $693.00K | - | - | - |
| Goodwill | - | - | $0.00 | $0.00 | $0.00 | $65.80M |
| Total assets | $105.01M | $124.18M | $118.09M | $136.46M | $137.62M | $265.67M |
| Accounts payable | $11.28M | $10.60M | $10.44M | - | - | $19.25M |
| Total current liabilities | $54.66M | $63.06M | $62.23M | $69.02M | $64.44M | $109.44M |
| Long-term debt | $9.10M | $10.89M | $10.88M | $15.00M | $15.00M | - |
| Total liabilities | - | - | - | $97.11M | $91.53M | $128.10M |
| Retained earnings | -$347.79M | -$333.54M | -$319.97M | -$304.13M | -$288.47M | -$178.30M |
| Total equity | $35.27M | $18.97M | $27.72M | $39.36M | $46.09M | $137.57M |